CannaPharmaRX, Inc. Reports Director and Officer Changes
Ticker: CPMD · Form: 8-K · Filed: Sep 17, 2024 · CIK: 1081938
| Field | Detail |
|---|---|
| Company | Cannapharmarx, Inc. (CPMD) |
| Form Type | 8-K |
| Filed Date | Sep 17, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, officer-appointment
TL;DR
Board shakeup at CannaPharmaRX, Inc. - new directors and officers appointed.
AI Summary
CannaPharmaRX, Inc. filed an 8-K on September 17, 2024, reporting events as of September 9, 2024. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in leadership can introduce uncertainty regarding future company direction and performance.
Key Players & Entities
- CannaPharmaRX, Inc. (company) — Registrant
- September 9, 2024 (date) — Earliest event reported
- September 17, 2024 (date) — Date of report
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates events related to the departure of directors or certain officers, election of directors, and appointment of certain officers.
When were these changes effective?
The earliest event reported was as of September 9, 2024.
What is the exact name of the company filing this report?
The exact name of the registrant is CannaPharmaRX, Inc.
In which jurisdiction was CannaPharmaRX, Inc. incorporated?
CannaPharmaRX, Inc. was incorporated in Delaware.
What is the IRS Employer Identification Number for CannaPharmaRX, Inc.?
The IRS Employer ID No. for CannaPharmaRX, Inc. is 27-4635140.
Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-09-17 10:39:59
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share CPMD OTC Markets Indicate
Filing Documents
- canna_8k.htm (8-K) — 29KB
- 0001683168-24-006456.txt ( ) — 200KB
- cpmd-20240909.xsd (EX-101.SCH) — 3KB
- cpmd-20240909_lab.xml (EX-101.LAB) — 33KB
- cpmd-20240909_pre.xml (EX-101.PRE) — 22KB
- canna_8k_htm.xml (XML) — 4KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of Chief Executive Officer Pursuant to notice provided to the Company, Dean Medwid stepped down as the Chief Executive Officer ("CEO") of CannaPharmaRX, Inc. (the "Company") for personal reasons. There was no disagreement between Mr. Medwid and the Company on any matter related to the Company's operations, policies or practices that led to Mr. Medwid's resignation as CEO. The Company appreciates Mr. Medwid's dedication and service to the Company. The Company is looking to work with Mr. Medwid on a smooth transition and minimal interruption to our operations. The Company's Board of Directors has started the process of finding a suitable replacement CEO for the Company. In the interim, the Board of Directors will work collectively with Company staff and employees to manage the day-to-day operations of the Company. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. CANNAPHARMARX, INC. September 17, 2024 B y: /s/ Rick Orman Name: Title: Rick Orman Chairman of the Board 3